
Zomedica Corp. ZOM
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Zomedica Corp. Current Ratio 2011-2026 | ZOM
Current Ratio Jährlich Zomedica Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 | 17.7 | 19.2 | 22.9 | 29.5 | 41.3 | 0.866 | 1.62 | 5.14 | 12.9 | 37 | 21 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.3 | 0.866 | 18.3 |
Current Ratio Vierteljährlich Zomedica Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.7 | 12.3 | 13.6 | 17.7 | 19 | 19.7 | - | 19.2 | 19.4 | 18 | 16.9 | 22.9 | 20.9 | 29.8 | 31.1 | 29.5 | 46.7 | 65.4 | 95.4 | 21.2 | 21.2 | 21.2 | 21.2 | 2 | 2 | 2 | 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 95.4 | 2 | 23.1 |
Current Ratio anderer Aktien in der Arzneimittelhersteller
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AcelRx Pharmaceuticals
ACRX
|
2.34 | - | 7.5 % | $ 6.35 M | ||
|
Assertio Holdings
ASRT
|
1.54 | $ 18.6 | - | $ 119 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.944 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
0.961 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
1.59 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
1.95 | - | - | $ 50.1 M | ||
|
Endo International plc
ENDP
|
1.77 | - | - | $ 28.9 M | ||
|
Evoke Pharma
EVOK
|
0.733 | - | - | $ 36.6 M | ||
|
Agile Therapeutics
AGRX
|
0.386 | - | 10.11 % | $ 58.2 M | ||
|
Alimera Sciences
ALIM
|
1.43 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
0.894 | - | -23.39 % | $ 1.76 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
1.43 | $ 3.07 | -0.97 % | $ 43.2 M | ||
|
Cronos Group
CRON
|
6.63 | $ 2.52 | - | $ 1.31 B | ||
|
Avadel Pharmaceuticals plc
AVDL
|
1.82 | - | - | $ 2.06 B | ||
|
Jupiter Wellness
JUPW
|
6.86 | - | - | $ 33.6 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
9.82 | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
1.85 | - | 2.45 % | $ 38.1 M | ||
|
Neoleukin Therapeutics
NLTX
|
12.2 | - | - | $ 193 M | ||
|
Bausch Health Companies
BHC
|
0.997 | $ 5.26 | - | $ 1.92 B | ||
|
Harrow Health
HROW
|
1.15 | $ 35.43 | - | $ 1.3 B | ||
|
Aurora Cannabis
ACB
|
3.49 | $ 3.37 | - | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
2.13 | $ 0.99 | - | $ 106 M | ||
|
PetIQ
PETQ
|
2.4 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
3.65 | - | - | $ 5.07 M | ||
|
Radius Health
RDUS
|
0.418 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.62 | - | -4.76 % | $ 65.3 M | ||
|
Organogenesis Holdings
ORGO
|
4.42 | $ 2.26 | - | $ 298 M | ||
|
Pacira BioSciences
PCRX
|
2 | $ 22.53 | - | $ 1.04 B | ||
|
Eagle Pharmaceuticals
EGRX
|
2.35 | - | -39.89 % | $ 27.7 M | ||
|
Evolus
EOLS
|
0.907 | $ 4.08 | - | $ 263 M | ||
|
OrganiGram Holdings
OGI
|
4 | $ 1.37 | - | $ 402 M | ||
|
Emergent BioSolutions
EBS
|
1.55 | $ 7.85 | - | $ 402 M | ||
|
Solid Biosciences
SLDB
|
4.43 | $ 7.74 | - | $ 677 M | ||
|
Tilray
TLRY
|
4.41 | $ 6.46 | - | $ 3.99 B | ||
|
Sundial Growers
SNDL
|
5.69 | $ 1.31 | - | $ 3.37 M | ||
|
Veru
VERU
|
2.15 | $ 2.48 | - | $ 334 M | ||
|
Viatris
VTRS
|
1.73 | $ 13.16 | - | $ 15.8 B | ||
|
Lannett Company
LCI
|
0.659 | - | 1.15 % | $ 7.11 M | ||
|
cbdMD
YCBD
|
1.23 | $ 0.72 | 1.95 % | $ 3.11 M | ||
|
OptiNose
OPTN
|
0.554 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
3.07 | - | -27.8 % | $ 2.56 M | ||
|
Relmada Therapeutics
RLMD
|
12.5 | $ 6.75 | - | $ 266 M | ||
|
Rockwell Medical
RMTI
|
2.83 | $ 0.95 | - | $ 34.2 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
1.48 | $ 2.21 | - | $ 2.74 M | ||
|
SCYNEXIS
SCYX
|
6.12 | $ 0.96 | - | $ 47.9 M | ||
|
Zynerba Pharmaceuticals
ZYNE
|
5.98 | - | - | $ 55.5 M | ||
|
Tricida
TCDA
|
1 | - | - | $ 3.25 M | ||
|
China Pharma Holdings
CPHI
|
3.75 | $ 0.64 | - | $ 2.75 M | ||
|
TherapeuticsMD
TXMD
|
3.49 | $ 2.02 | - | $ 23.4 M |